Health
New drug candidate suppresses SARS-CoV-2 replication – News-Medical.Net
Researchers at Stanford University and Utah State University have developed a novel inhibitor of the coronavirus main protease (Mpro) that effectively suppresses the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers at Stanford University and Utah State University have developed a novel inhibitor of the coronavirus main protease (Mpro) that effectively suppresses the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
SARS-CoV-2 is the agent that causes coronavirus disease 2019 (COVID-19), and Mpro is an essential protein required for the life cycle of coronaviruses.
Currently, there is an intense interest in discovering effective inhibitors of SARS-CoV-2 Mpro. S…
-
General14 hours agoAbattoir worker in serious condition after workplace accident in Echuca
-
General19 hours ago‘Sovereign citizens’ sentenced to prison term in Western Australia for defiance of court order
-
Noosa News22 hours agoBroncos media boss Melissa Mallet to face court over alleged drink-driving crash
-
General14 hours agoWoman who reported NSW MP Gareth Ward’s alleged sex crimes cross-examined